YAP1 and cancer: Considering the lack of effective strategies directly targeting deregulated YAP1 in human cancers, we next screened for small molecule compounds to mitigate YAP1 stability by determining the fluorescence intensity in A2780 cells stably expressing GFP-YAP1 (Fig. 1A).